Furosemide: Common Indications and Normal Adult Dosing
FDA-Approved Indications
Furosemide is FDA-approved for treating edema associated with congestive heart failure, cirrhosis of the liver, renal disease (including nephrotic syndrome), and hypertension in adults. 1
Standard Adult Dosing by Indication
Congestive Heart Failure
Acute Decompensated Heart Failure:
- Initial dose: 20-40 mg IV bolus over 1-2 minutes 2
- For patients already on chronic oral furosemide >40 mg/day at home, start with 80 mg IV rather than 40 mg 2
- Maximum total dose should remain <100 mg in the first 6 hours and <240 mg during the first 24 hours 2
- If inadequate response, double the dose rather than giving repeated small doses 2
Chronic Heart Failure:
- Starting dose: 20-40 mg orally once daily in the morning 2, 3
- May be given as 20-40 mg once or twice daily depending on response 2
- Maintenance doses typically range from 20-80 mg/day 3
- Doses exceeding 160 mg/day indicate advanced disease requiring treatment escalation or combination therapy 2
Cirrhosis with Ascites
Initial regimen: Furosemide 40 mg combined with spironolactone 100 mg as a single morning dose 2
- Maintain the 100:40 spironolactone-to-furosemide ratio when escalating 2
- Increase both drugs simultaneously every 3-5 days if weight loss <2 kg/week 2
- Maximum furosemide dose: 160 mg/day (exceeding this indicates diuretic resistance requiring paracentesis) 2
- Oral administration is strongly preferred over IV to avoid acute GFR reduction 2
Nephrotic Syndrome
Severe edema:
- Starting dose: 0.5-2 mg/kg per dose IV or orally, up to six times daily 2
- Maximum: 10 mg/kg per day 2
- High doses (>6 mg/kg/day) should not be given for periods longer than 1 week 2
- May administer IV furosemide 0.5-2 mg/kg at the end of albumin infusions in the absence of marked hypovolemia or hyponatremia 2
Hypertension
- Typical dose: 40 mg twice daily initially 1
- May be used alone or in combination with other antihypertensive agents 1
- Note: Patients inadequately controlled with thiazides will likely not be controlled with furosemide alone 1
Critical Dosing Considerations
Route of Administration
- IV administration is preferred in acute situations requiring rapid diuresis 2
- Oral administration has variable bioavailability (especially in edematous states) but is preferred for chronic management in cirrhosis 2, 4
- Infusions >250 mg must be given over 4 hours to prevent ototoxicity 2
Monitoring Requirements
- Target weight loss: 0.5 kg/day without peripheral edema; 1.0 kg/day with peripheral edema 2
- Check electrolytes (sodium, potassium) every 3-7 days during initial titration 2
- Monitor renal function and blood pressure regularly 2
- Place bladder catheter in acute settings to assess hourly urine output 2
Absolute Contraindications
- Systolic blood pressure <90 mmHg without circulatory support 2
- Marked hypovolemia or anuria 2
- Severe hyponatremia (serum sodium <120-125 mmol/L) 2
- Severe hypokalemia (<3 mmol/L) 2
Common Pitfalls to Avoid
- Never give furosemide to hypotensive patients expecting hemodynamic improvement—it worsens tissue perfusion 2
- Avoid evening doses as they cause nocturia and poor adherence without improving outcomes 2
- In acute pulmonary edema, furosemide should not be used as monotherapy; concurrent IV nitroglycerin is superior 2
- When reaching ceiling doses (80-160 mg/day), add a second diuretic class (thiazide or aldosterone antagonist) rather than further escalating furosemide alone 2